Fingerprint
Dive into the research topics of 'Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial
Ta Chung Chao, Zyting Chu, Ling Ming Tseng, Tzeon Jye Chiou, Ruey Kuen Hsieh, Wei Shu Wang, Chueh Chuan Yen, Muh Hwa Yang, Liang Tsai Hsiao, Jin Hwang Liu, Po Min Chen*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations